Paolo Bevilacqua

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Recent advancements in imaging diagnostics have focused on the use of nanostructures that entrap Magnetic Resonance Imaging (MRI) Contrast Agents (CAs), without the need to chemically modify the clinically approved compounds. Nevertheless, the exploitation of microfluidic platforms for their controlled and continuous production is still missing. Here, a(More)
  • 1